SUPPLEMENTARY INFORMATION
|
|
- Malcolm Mitchell
- 5 years ago
- Views:
Transcription
1 Supplementary information S1 Studies of the effect of AKI duration on outcomes Study Study group (n) Criteria for AKI Definition of RR Outcomes Uchino et al. All patients admitted to (2010) 1 a university-affiliated hospital (20,126) Coca et al. Diabetic patients (2010) 2 from 123 Veterans Affairs medical centres undergoing their first non-cardiac surgery. (35,302) Kellum et al. Academic medical centre (2015) 3 database of critically ill patients who were classified according to the maximum KDIGO criteria met during hospitalization (32,045) Sood et al. AKI of any RIFLE severity (2014) 4 prevalent at shock (5,443) Brown et al. Patients undergoing (2010) 5 cardiac surgery (4,987) Perinel et al. Critically ill patients with (2015) 6 ICU stay >3 days (447) and UO and UO Reversal to no AKI RIFLE class within 72 h of AKI onset Reversal of to <17.7 μmol/l (<0.2 mg/dl) above the preoperative value within 48 h Reversal to no AKI KDIGO class within 3 days Reversal of to baseline value within 24 h Reversal to no AKI RIFLE class within 72 h of AKI onset Reversal of oliguria (in the absence of diuretic treatment) and/or 50% decrease in and/or return to the baseline value RR in 14.8% of patients; persistent AKI in 29.1% Patients with TA had a significantly higher odds ratio for hospital mortality (2.26; 95% CI ) than patients without AKI Mortality was lowest in those with AKI duration 2 days, regardless of stage Median survival was 3.5 years for patients with short duration AKI (<2 days), 2.9 years for those with medium-duration AKI (3 6 days), and 2.1 years for patients with long-duration AKI ( Likelihood of death or dialysis at 1 year was higher in patients with persistent AKI than in those with transient AKI (excluding death or RRT during the index hospitalization) RR in 21.2% of patients; persistent AKI in 53.0% RR within 1 2 days in 18% of patients; persistent AKI (for 3 6 days) in 11%; >7 days in 9% RR in 29.6% of patients; persistent AKI in 38.9% AKI, acute kidney injury; ICU, intensive care unit; RR, rapid reversal of AKI; RRT, renal replacement therapy;, serum creatinine; TA, transient azotaemia, UO, urine output. Supplementary information S2 Tests to differentiate rapid reversal of AKI from persistent AKI Study Test Summary Brown et al. Risk score Perioperative predictors of AKI duration following cardiac surgery (2012) 7 Schnell et al. Resistive (2012) 8 index Dewitte et al. Resistive (2012) 9 index Platt et al. Resistive (1991) 10 index Darmon et al. Resistive (2011) 11 index Ninet et al. Resistive (2015) 12 index de Geus et al. Cystatin C (2011) 13 and NGAL Basu et al. Cystatin C (2014) 14 and NGAL Basu et al. Biomarkers (2014) 14 and renal angina index In patients with AKI, resistive index predicted persistent AKI Resistive index was similar in transient and persistent AKI Resistive index performed well for diagnosing persistent AKI Intermediate level of resistive index 0.71 ( ) in the transient AKI group Meta-analysis of resistive index studies AKI, acute kidney injury; NGAL, neutrophil gelatinase-associated lipocalin. Urinary NGAL differentiated rapid reversal from persistent AKI on admission Cystatin C and NGAL demonstrated greater likelihood ratios than changes in serum creatinine for persistent AKI Plasma NGAL, matrix metalloproteinase 8 and neutrophil elastase improve the net reclassification index for the renal angina index
2 Supplementary information S3 Studies of recovery including nondialysis-requiring AKI using serum creatinine Study Population (n) AKI definition Recovery definition (outcome) Lins et al. Prospective, (2006) 15 Belgium (145) Ali et al. Retrospective, UK (2007) 16 (474) Liano et al. Retrospective, (2007) 17 Spain (187) Jones et al. Retrospective, (2012) 18 propensity score-matched, hospitalized with normal baseline kidney function, USA (3,809) Bucaloiu et al. Retrospective, (2012) 19 propensity score-matched, USA (5,262) Pannu et al. Retrospective, (2013) 20 Canada (3,239) Korenkevych et al. (2015) 21 Retrospective, hospitalized surgical patients, USA (46,299) >2 mg/dl* and survived hospitalization RIFLE + peak >1.7 mg/dl (males) or 1.5 mg/dl (females) ATN, >2 mg/dl with baseline <1.4 mg/dl ICD % increase in and recovery 50% increase in and recovery KDIGO CrCl >60 (32%) CrCl (58%) CrCl <15 (10%) Full: below threshold or baseline (68%) Partial: above threshold (5%) None: RRT at 90 days (n = 2) Unknown (27%) Complete: 1.4 mg/ dl (42%) Partial: > mg/ dl (57%) None: near peak or still on RRT at discharge (1%) Within 10% of baseline (19%) Timing of recovery assessment At discharge Future mortality recovery status 90 days recovery status At discharge (mean stay 54 days) Within 7 days of discharge Patients with complete recovery had better survival than those with nonrecovery All-cause mortality: RR 1.08 ( ) among those who did not recover <90% baseline egfr 90 days Recovered AKI versus no AKI: ahr 1.50 (95% CI ) Within 25% of baseline (70% achieved overall) KDIGO 1 3 Complete: within 50% of baseline (74%) Partial: >50% but not on RRT (22%) None: RRT (4%) With incident CKD added: ahr 1.18 (95% CI ) 90 days Recovered versus non-recovered: ahr 1.26 (95% CI ) Discharge Mortality at 90 days versus no AKI ahr Full recovery: Stage 1: 1.48 ( ) Stage 2: 2.16 ( ) Stage 3: 5.73 ( ) Partial recovery: Stage 1: 2.73 ( ) Stage 2: 8.81 ( ) Stage 3: ( ) None: ( ) Future renal outcome Incident CKD: AKI versus no AKI HR 3.82 ( ) among those who did not recover Recovered AKI versus no AKI: ahr 1.95 (95% CI ) Recovered versus non-recovered for doubling of or ESRD: ahr 4.13 (95% CI )
3 Supplementary information S3 (cont.) Studies of recovery including nondialysis-requiring AKI using serum creatinine Heung et al. Retrospective, US (2015) 22 veterans (104,764) Kellum et al. Prospective, septic (2016) 23 shock (1,243) KDIGO 1 3 KDIGO stage 2 3 To within 0.3 mg/dl of baseline : 67% within 2 days 13% between 3 10 days 12% still elevated after 10 days 8% unknown Complete recovery: return to within 1.5 x baseline Partial: improvement of one KDIGO stage but not complete 2 days, 3 10 days, >10 days Discharge Not evaluated 1 year survival Complete: 64% Partial: 64% No recovery: 13% No AKI: 61% RR of incident CKD at 1 year, recovered versus no AKI: 2 days: Stage 1: 1.43 ( ) Stage 2: 1.80 ( ) Stage 3: 1.96( ) 3 10 days: Stage 1: 2.00( ) Stage 2: 1.91( ) Stage 3: 2.20( ) Still elevated >10 days: Stage 1: 2.65 ( ) Stage 2: 3.31 ( ) Stage 3: 3.59 ( ) Unknown: Stage 1: 1.48 ( ) Stage 2: 2.08 ( Stage 3: 2.21 ( ) *Multiply by 88.4 to obtain value in μmol/l. ahr, adjusted hazard ratio; AKI, acute kidney injury; ATN, acute tubular necrosis; CCl, creatinine clearance (units ml/ min/1.73 m 2 ); CKD, chronic kidney disease; egfr, estimated glomerular filtration rate; ESRD, end-stage renal disease; RR, relative risk; RRT, renal replacement therapy;, serum creatinine.
4 Supplementary information S4 Studies of non-creatinine-based biomarkers to predict or assess renal recovery after AKI Study Setting Biomarkers Recovery outcomes Performance Hall et al. 91 adult kidney (2009) 24 transplant recipients Srisawat et al. 189 adults with (2011) 25 community-acquired pneumonia (post hoc analysis of GenIMS) Srisawat et al. 76 adults with (2011) 26 dialysis-requiring AKI from the ATN Study (BioMaRK) Hall et al. 78 adult kidney (2011) 27 transplant recipients Zhang et al. 232 adults AKI on (2012) 28 CRRT Murugan et al. 817 critically Ill adults (2014) 29 (BioMaRK) Meersch et al. 50 adult cardiac (2014) 30 surgery patients Pianta et al. 56 transplant (2015) 31 recipients Koyner et al. 692 critically Ill adults (2015) 32 with Stage 1 AKI (Sapphire study) Wang et al. 114 hospitalized (2015) 33 adults with AKIN stage 3 and nephrology consultation Urine NGAL, IL 18, KIM1 at 0, 6, 12, and 18 h after transplantation Plasma NGAL ungal, HGF, Ucyst, uil 18, NGAL/ MMP 9, urinary creatinine Plasma NGAL, IL 18, serum cystatin C discharge Dialysis-free survival for 60 days AUCs: NGAL IL KIM AUC 0.74 (95% CI ) AUCs for renal recovery: ungal, 0.70; Ucyst, 0.61; uil 18, 0.42; HGF, 0.74; ungal/mmp 9, 0.53; urinary creatinine, 0.66 Combining biomarkers with clinical variables improved the AUC (0.94) and NRI (63.3%). No difference in NGAL or IL 18 between patients with and without DGF Day 1 cystatin C AUC 0.83 (95% CI ) Serum cystatin C Dialysis independence AUC for nonrecovery 0.91(95% CI ) Plasma IL 1β, IL 6, IL 8, IL 10, IL 18, MIF, TNF, TNFR1, TNFR2, DR 5, GM CSF TIMP 2*IGFBP7, NGAL Urine TIMP2*IGFB7, VEGF A, MCP 1, TFF3, CXCL16 TIMP 2*IGFBP7 Urine L FABP Dewitte et al. (2015) critically Ill adults Urine TIMP 2*IGFBP7, pngal at inclusion and 24 h later Pike et al. 817 critically (2015) 35 ill adults with dialysis-requiring AKI (BioMaRK) Reese et al. 1,304 deceased (2015) 36 donor urine samples Plasma IL 6, IL 8, IL 10, IL 19, MIF, TNFR1, TNFR2, DR 5 Donor urine NGAL, KIM 1, IL 18, L FABP, microalbuminuria 60 days Renal recovery at discharge (return to baseline ) All-cause mortality or RRT at 9 months Alive without need for RRT, AKIN 3, and minimum CrCl of 20 ml/min at discharge 1.5 times baseline or 0.35 mg/dl* with reversal of oliguria within 48 h 60 days DGF (RRT within Increased concentrations of plasma IL 8, IL 18, MIF and TNFR1 were associated with slower renal recovery and increased mortality TIMP 2*IGFBP7 AUC 0.79 (95% CI ) NGAL AUC 0.48 (95% CI ) AUCs for predicting DGF (utimp 2*IGFBP7 0.76; VEGF A 0.81; utimp ; uigfbp7 0.71) Adjusted HRs: 1.44 (95% CI ) for levels > (95% CI ) for levels >2.0 AUC for nonrecovery 0.91 (95%CI ) AUCs: TIMP 2*IGFBP pngal AUC ranges High donor ungal levels were significantly associated with recipient DGF with RR 1.21 (highest versus lowest tertiles) Addition of urinary biomarkers did not improve AUC, IDI, and NRI At 6 months, donor urinary biomarkers added minimal value in predicting allograft function. *Multiply by 88.4 to obtain value in μmol/l. AKI, acute kidney injury; AUC, area under the curve; CrCl, creatinine clearance; CRRT, continuous renal replacement therapy; CXCL16, C X C motif chemokine 16; DGF, delayed graft function; DR 5, death receptor; GenMS, genetic and inflammatory markers of sepsis study; HGF, hepatocyte growth factor; GM CSF, granulocyte macrophage colony-stimulating factor; IDI, integrated discrimination index; IGFBP, insulin-like growth factor-binding protein; KIM 1; kidney injury molecule 1 (also known as hepatitis A virus cellular receptor 1); L FABP, liver-type fatty acid binding protein; MCP 1, monocyte chemotactic protein 1; MIF, macrophage migration inhibitory factor; MMP 9, matrix metalloproteinase 9; NGAL, neutrophil gelatinase-associated lipocalin; pngal, plasma NGAL;, serum creatinine; NRI, net reclassification index; RRT, renal replacement therapy; TIMP, metalloproteinase inhibitor; TFF3, trefoil factor 3; TNF, tumour necrosis factor; TNFR, TNF receptor; Ucyst, urine cystatin C; uil 18, urinary IL 18; VEGF A, vascular endothelial growth factor A.
5 Supplementary information S5 The relationship between patient characteristics before RRT and kidney recovery Patient characteristics/factors Effect on renal recovery Effect on patient recovery Age Inverse association Inverse association Lower baseline kidney function Inverse association Inverse association AKI aetiology Uncertain effect Uncertain effect Comorbidities Inverse association Inverse association Non-renal organ dysfunction Inverse association Inverse association Fluid overload Inverse association Inverse association Recurrent AKI episode Inverse association Unknown effect Congestive heart failure Inverse association Unknown effect AKI, acute kidney injury. Supplementary information S6 Other factors involved in the care of patients with RRT-dependent AKI that might affect recovery Factors Effect on renal recovery Effect on patient recovery Logistics (for example, training, resource availability) No studies Unknown Transition from one RRT modality to another No studies Unknown Concurrent care (for example, antibiotic dosing, other medications, diuretics, transfusion, erythropoiesis stimulating agents) AKI, acute kidney injury; RRT, renal replacement therapy. No studies Anaemia is not associated with delayed recovery Unknown 1. Uchino, S., Bellomo, R., Bagshaw, S. M. & Goldsmith, D. Transient azotaemia is associated with a high risk of death in hospitalized patients. Nephrol. Dial. Transplant. 25, (2010). 2. Coca, S. G. et al. The duration of postoperative acute kidney injury is an additional parameter predicting long-term survival in diabetic veterans. Kidney Int. 78, (2010). 3. Kellum, J. A. et al. Classifying AKI by urine output versus serum creatinine level. J. Am. Soc. Nephrol. 26, (2015). 4. Sood, M. M. et al. Early reversible acute kidney injury is associated with improved survival in septic shock. J. Crit. Care 29, (2014). 5. Brown, J. R., Kramer, R. S., Coca, S. G. & Parikh, C. R. Duration of acute kidney injury impacts long-term survival after cardiac surgery. Ann. Thorac. Surg. 90, (2010). 6. Perinel, S. et al. Transient and persistent acute kidney injury and the risk of hospital mortality in critically ill patients: results of a multicenter cohort study. Crit. Care Med. 43, e269 e275 (2015). 7. Brown, J. R. et al. Determinants of acute kidney injury duration after cardiac surgery: an externally validated tool. Ann. Thorac. Surg. 93, (2012). 8. Schnell, D. et al. Renal resistive index better predicts the occurrence of acute kidney injury than cystatin C. Shock 38, (2012). 9. Dewitte, A. et al. Doppler resistive index to reflect regulation of renal vascular tone during sepsis and acute kidney injury. Crit. Care 16, R165 (2012). 10. Platt, J. F., Rubin, J. M. & Ellis, J. H. Acute renal failure: possible role of duplex Doppler US in distinction between acute prerenal failure and acute tubular necrosis. Radiology 179, (1991). 11. Darmon, M. et al. Diagnostic accuracy of Doppler renal resistive index for reversibility of acute kidney injury in critically ill patients. Intensive Care Med. 37, (2011). 12. Ninet, S. et al. Doppler-based renal resistive index for prediction of renal dysfunction reversibility: a systematic review and meta-analysis. J. Crit. Care 30, (2015). 13. de Geus, H., Bakker, J., Lesaffre, E. & lenoble, J. Neutrophil gelatinase-associated lipocalin at ICU admission predict for acute kidney injury in adult patients. Am. J. Respir. Crit. Care Med. 183, (2011). 14. Basu, R. K. et al. Incorporation of biomarkers with the renal angina index for prediction of severe AKI in critically ill children. Clin. J. Am. Soc. Nephrol. 9, (2014). 15. Lins, R. L., Elseviers, M. M. & Daelemans, R. Severity scoring and mortality 1 year after acute renal failure. Nephrol. Dial. Transplant. 21, (2006). 16. Ali, T. et al. Incidence and outcomes in acute kidney injury: a comprehensive population-based study. J. Am. Soc. Nephrol. 18, (2007). 17. Liano, F. et al. Long-term outcome of acute tubular necrosis: a contribution to its natural history. Kidney Int. 71, (2007). 18. Jones, J. et al. Association of complete recovery from acute kidney injury with incident CKD stage 3 and allcause mortality. Am. J. Kidney Dis. 60, (2012). 19. Bucaloiu, I. D. et al. Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury. Kidney Int. 81, (2012). 20. Pannu, N., James, M., Hemmelgarn, B., Klarenbach, S. & Alberta Kidney Disease Network. Association between AKI, recovery of renal function, and long-term outcomes after hospital discharge. Clin. J. Am. Soc. Nephrol. 8, (2013). 21. Korenkevych, D. et al. The pattern of longitudinal change in serum creatinine and 90 day mortality after major surgery. Ann. Surg. 263, (2016). 22. Heung, M. et al. Acute kidney injury recovery pattern and subsequent risk of CKD: an analysis of Veterans Health Administration Data. Am. J. Kidney Dis. 67, (2016). 23. Kellum, J. A. et al. The effects of alternative resuscitation strategies on acute kidney injury in patients with septic shock. Am. J. Respir. Crit. Care Med. 193, (2016). 24. Hall, I. E. et al. IL 18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. J. Am. Soc. Nephrol. 21, (2009). 25. Srisawat, N. et al. Plasma neutrophil gelatinaseassociated lipocalin predicts recovery from acute kidney injury following community-acquired pneumonia. Kidney Int. 80, (2011). 26. Srisawat, N. et al. Urinary biomarkers and renal recovery in critically ill patients with renal support. Clin. J. Am. Soc. Nephrol. 6, (2011). 27. Hall, I. E., Doshi, M. D., Poggio, E. D. & Parikh, C. R. A comparison of alternative serum biomarkers with creatinine for predicting allograft function after kidney transplantation. Transplantation 91, (2011). 28. Zhang, Z., Xu, X., Ni, H. & Jin, N. Serum cystatin C is associated with renal function recovery in critically ill patients undergoing continuous renal replacement therapy. Nephron Clin. Pract. 122, (2012). 29. Murugan, R. et al. Plasma inflammatory and apoptosis markers are associated with dialysis dependence and death among critically ill patients receiving renal replacement therapy. Nephrol. Dial. Transplant. 29, (2014). 30. Meersch, M. et al. Urinary TIMP 2 and IGFBP7 as early biomarkers of acute kidney injury and renal recovery following cardiac surgery. PLoS ONE 9, e93460 (2014). 31. Pianta, T. J. et al. Evaluation of biomarkers of cell cycle arrest and inflammation in prediction of dialysis or recovery after kidney transplantation. Transpl. Int. 28, (2015). 32. Koyner, J. L. et al. Tissue inhibitor metalloproteinase 2 (TIMP 2)IGF-binding protein 7 (IGFBP7) levels are associated with adverse long-term outcomes in patients with AKI. J. Am. Soc. Nephrol. 26, (2015). 33. Wang, L. et al. Urinary liver-type fatty acid-binding protein predicts recovery from acute kidney injury. Clin. Nephrol. 84, (2015). 34. Dewitte, A. et al. Kinetic egfr and novel AKI biomarkers to predict renal recovery. Clin. J. Am. Soc. Nephrol. 10, (2015). 35. Pike, F. et al. Biomarker enhanced risk prediction for adverse outcomes in critically ill patients receiving RRT. Clin. J. Am. Soc. Nephrol. 10, (2015). 36. Reese, P. P. et al. Associations between deceased-donor urine injury biomarkers and kidney transplant outcomes. J. Am. Soc. Nephrol. 27, (2016).
ENDPOINTS FOR AKI STUDIES
ENDPOINTS FOR AKI STUDIES Raymond Vanholder, University Hospital, Ghent, Belgium SUMMARY! AKI as an endpoint! Endpoints for studies in AKI 2 AKI AS AN ENDPOINT BEFORE RIFLE THE LIST OF DEFINITIONS WAS
More informationUne promenade dans l'épidémiologie de l'insuffisance rénale aiguë en quatre étapes
Une promenade dans l'épidémiologie de l'insuffisance rénale aiguë en quatre étapes Fernando Liaño Hospital Universitario Ramón y Cajal Madrid, España Genéve, 14-12-2012 Une promenade dans l'épidémiologie
More informationBiomarkers for the Prevention of Drug Induced AKI (D-AKI)
Biomarkers for the Prevention of Drug Induced AKI (D-AKI) Sandra Kane-Gill, PharmD, MSc, FCCM, FCCP Associate Professor, University of Pittsburgh Critical Care Medication Safety Pharmacist, UPMC OBJECTIVE
More informationThe 2012 KDIGO guidelines on Acute Kidney Injury-
The 2012 KDIGO guidelines on Acute Kidney Injury- Is there a need for an update and have the guidelines improved AKI prognosis? Norbert Lameire, MD,PhD Em prof of Medicine and Nephrology University Hospital
More informationUrinary biomarkers in acute kidney injury. Max Bell MD, PhD Karolinska University Hospital Solna/Karolinska Institutet
Urinary biomarkers in acute kidney injury Max Bell MD, PhD Karolinska University Hospital Solna/Karolinska Institutet Development of AKI-biomarkers Early markers of AKI, do we need them? GFR drop Normal
More informationA08 Using Kidney Biomarkers for AKI 2: Differential Diagnosis, Interventions and Prognosis
A08 Using Kidney Biomarkers for AKI 2: Differential Diagnosis, Interventions and Prognosis Kent Doi, MD, PhD Emergency and Critical Care Medicine, The Univ of Tokyo, Japan Using kidney biomarkers: Key
More informationAcute Kidney Injury for the General Surgeon
Acute Kidney Injury for the General Surgeon UCSF Postgraduate Course in General Surgery Maui, HI March 20, 2011 Epidemiology & Definition Pathophysiology Clinical Studies Management Summary Hobart W. Harris,
More informationNovel Biomarkers in Critically Ill Patients and the Emergency Room
Novel Biomarkers in Critically Ill Patients and the Emergency Room Jay L. Koyner MD Section of Nephrology University of Chicago Research Funding: NIDDK, Abbvie, Astute, Argutus Outline Background / Pitfalls
More informationchanging the diagnosis and management of acute kidney injury
changing the diagnosis and management of acute kidney injury NGAL NGAL is a novel biomarker for diagnosing acute kidney injury (AKI). The key advantage of NGAL is that it responds earlier than other renal
More informationNGAL. Changing the diagnosis of acute kidney injury. Key abstracts
NGAL Changing the diagnosis of acute kidney injury Key abstracts Review Neutrophil gelatinase-associated lipocalin: a troponin-like biomarker for human acute kidney injury. Devarajan P. Nephrology (Carlton).
More informationThe Link Between Acute and Chronic Kidney Disease. John Arthur, MD, PhD
The Link Between Acute and Chronic Kidney Disease John Arthur, MD, PhD Conventional Dogma Conventional dogma was that if a patient survived and recovered from AKI, he was unlikely to have long-term sequela.
More informationLas dos caras de la cretinina sérica The two sides of serum creatinine
Las dos caras de la cretinina sérica The two sides of serum creatinine ASOCIACION COSTARRICENSE DE MEDICINA INTERNA San José, Costa Rica June 2017 Kianoush B. Kashani, MD, MSc, FASN, FCCP 2013 MFMER 3322132-1
More informationAccepted Manuscript. Epidemiology of Cardiac Surgery Associated Acute Kidney Injury. Eric AJ. Hoste, Wim Vandenberghe
Accepted Manuscript Epidemiology of Cardiac Surgery Associated Acute Kidney Injury Eric AJ. Hoste, Wim Vandenberghe PII: S1521-6896(17)30079-4 DOI: 10.1016/j.bpa.2017.11.001 Reference: YBEAN 968 To appear
More informationInterest of NGAL as early marker of Acute Kidney Injury CLINIQUES UNIVERSITAIRES SAINT-LUC
Interest of NGAL as early marker of Acute Kidney Injury P Wallemacq, Clinical Chemistry Department, M Mourad, Surgery and Abdominal Transplantation Cliniques universitaires St Luc, Université Catholique
More informationAKI: definitions, detection & pitfalls. Jon Murray
AKI: definitions, detection & pitfalls Jon Murray Previous conventional definition Acute renal failure (ARF) An abrupt and sustained decline in renal excretory function due to a reduction in glomerular
More informationOptimal Use of Iodinated Contrast Media In Oncology Patients. Focus on CI-AKI & cancer patient management
Optimal Use of Iodinated Contrast Media In Oncology Patients Focus on CI-AKI & cancer patient management Dr. Saritha Nair Manager-Medical Affairs-India & South Asia GE Healthcare Context Cancer patients
More informationSeverity and Outcome of Acute Kidney Injury According to Rifle Criteria in the Intensive Care Unit
BANTAO Journal 2010; 8 (1): 35-39 BJ BANTAO Journal Original Article Severity and Outcome of Acute Kidney Injury According to Rifle Criteria in the Intensive Care Unit Albana Gjyzari 1, Elizana Petrela
More informationNeutrophil Gelatinase-Associated Lipocalin as a Biomarker of Acute Kidney Injury in Patients with Morbid Obesity Who Underwent Bariatric Surgery
Published online: October 31, 213 1664 5529/13/31 11$38./ This is an Open Access article licensed under the terms of the Creative Commons Attribution- NonCommercial 3. Unported license (CC BY-NC) (www.karger.com/oa-license),
More informationAdding Insult to Injury. Marlies Ostermann Consultant in Nephrology & Critical Care Guy s & St Thomas Hospital, London
Acute Kidney Injury Adding Insult to Injury Marlies Ostermann Consultant in Nephrology & Critical Care Guy s & St Thomas Hospital, London Content 1. Brief review of AKI and its impact 2. Comments on the
More informationHeart Failure and Cardio-Renal Syndrome 1: Pathophysiology. Biomarkers of Renal Injury and Dysfunction
CRRT 2011 San Diego, CA 22-25 February 2011 Heart Failure and Cardio-Renal Syndrome 1: Pathophysiology Biomarkers of Renal Injury and Dysfunction Dinna Cruz, M.D., M.P.H. Department of Nephrology San Bortolo
More informationAcute Kidney Injury. Amandeep Khurana, MD Southwest Kidney Institute
Acute Kidney Injury Amandeep Khurana, MD Southwest Kidney Institute 66 yr white male w/ DM, HTN, CAD admitted to an OSH w/ E Coli UTI on 7/24/16, developed E Coli bacteremia and Shock (on vaso + levo)
More informationAcute Kidney Injury (AKI) How Wise is Early Dialysis in Critically Ill Patients? Modalities of Dialysis
Acute Kidney Injury (AKI) How Wise is Early Dialysis in Critically Ill Patients? A common condition in ICU patients Associated with high mortality and morbidity Renal Replacement Therapy (RRT) is the cornerstone
More informationAKI-6 Epidemiology of Acute Kidney Injury
FACULTY OF MEDICINE AND HEALTH SCIENCES Academic Year 2011-2012 AKI-6 Epidemiology of Acute Kidney Injury Anne NOBELS Promotor: Prof. Dr. E. Hoste Co-promotor: Prof. Dr. J. Kellum (Pittsburg) Dissertation
More informationPro-enkephalin and Renal Disease. Alan H. Wu, Ph.D. University of California, San Francisco 12 th Annual UCSD Biomarkers of Cardiac Disease
Pro-enkephalin and Renal Disease Alan H. Wu, Ph.D. University of California, San Francisco 12 th Annual UCSD Biomarkers of Cardiac Disease The presenter has received relevant grants and /or consulting
More informationDEFINITION, CLASSIFICATION AND DIAGNOSIS OF ACUTE KIDNEY INJURY
DEFINITION, CLASSIFICATION AND DIAGNOSIS OF ACUTE KIDNEY INJURY JOSÉ ANTÓNIO LOPES, MD, PhD Faculty of Medicine, University of Lisbon Department of Nephrology and Renal Transplantation Centro Hospitalar
More informationNGAL Connect to the kidneys
NGAL Connect to the kidneys Acute kidney injury (AKI) An imposing medical and diagnostic challenge >13 million AKI patients each year ~ 30% with fatal outcome Cardiac surgery > 1 million patients/year
More informationNGAL, a new markers for acute kidney injury
NGAL, a new markers for acute kidney injury Prof. J. Delanghe, MD, PhD Dept. Clinical Chemistry Ghent University Lecture Feb 8, 2011 Serum creatinine is an inadequate marker for AKI. > 50% of renal
More informationWhat s new in kidneys a renal update for Anaesthetists
What s new in kidneys a renal update for Anaesthetists Thursday 11 th December 2014 Roslyn Simms Clinical Lecturer in Nephrology Renal update What s new/update AKI When to start RRT in AKI? Perioperative
More informationFluid Management in Critically Ill AKI Patients
Fluid Management in Critically Ill AKI Patients Sang Kyung Jo, MD, PhD Department of Internal Medicine Korea University Medical College KO/MG31/15-0017 Outline Fluid balance in critically ill patients:
More informationThe Duration of Postoperative Acute Kidney Injury Predicts In-Hospital Mortality in Surgical Patients
Original Article Elmer Press The Duration of Postoperative Acute Kidney Injury Predicts In-Hospital Mortality in Surgical Patients Hung-Chieh Wu a, Yu-Wei Chen b, c, d, Wei-Jie Wang a, e, Jui-Tsung Ting
More informationUpdate in. Acute Kidney Injury. Mark Devonald Consultant Nephrologist. Nottingham AKI Research Group
Update in Acute Kidney Injury Mark Devonald Consultant Nephrologist If you stay awake you might hear about Why AKI is important Some cases to illustrate some specific points A couple of updates on AKI
More informationAKI Risk Assessment, Prevention & Early Detection. Dr Lui G Forni Worthing Hospital, Brighton & Sussex Medical School
AKI Risk Assessment, Prevention & Early Detection Dr Lui G Forni Worthing Hospital, Brighton & Sussex Medical School Risk Assessment Prevention Early Detection I won t tell you how many In slides 25 I
More informationDoppler ultrasound, see Ultrasonography. Magnetic resonance imaging (MRI), kidney oxygenation assessment 75
Subject Index Acidemia, cardiorenal syndrome type 3 146 Acute Dialysis Quality Initiative (ADQI) acute kidney injury biomarkers, see Acute kidney injury; specific biomarkers cardiorenal syndrome, see specific
More informationTransient versus Persistent Acute Kidney Injury and the Diagnostic Performance of Fractional Excretion of Urea in Critically Ill Patients
Original Paper Received: June 27, 2013 Accepted: November 29, 2013 Published online: January 11, 2014 Transient versus Persistent Acute Kidney Injury and the Diagnostic Performance of Fractional Excretion
More informationChapter 5: Acute Kidney Injury
Chapter 5: Acute Kidney Injury In 2015, 4.3% of Medicare fee-for-service beneficiaries experienced a hospitalization complicated by Acute Kidney Injury (AKI); this appears to have plateaued since 2011
More informationHow and why to measure renal function in patients with liver disease?
ow and why to measure renal function in patients with liver disease? P. Angeli, Dept. of Medicine, Unit of Internal Medicine and epatology (), University of Padova (Italy) pangeli@unipd.it 10th Paris epatology
More informationAcute kidney injury patterns and outcomes in low-risk versus high-risk critically ill patients admitted to the medical intensive care unit
Original article Acute kidney injury patterns and outcomes in low-risk versus high-risk critically ill patients admitted to the medical intensive care unit Cyriacus U Anaele MD, Gabriela Suarez MD, Sofia
More informationFluid Resuscitation in Critically Ill Patients with Acute Kidney Injury (AKI)
Fluid Resuscitation in Critically Ill Patients with Acute Kidney Injury (AKI) Robert W. Schrier, MD University of Colorado School of Medicine Denver, Colorado USA Prevalence of acute renal failure in Intensive
More informationSupplementary Online Content
Supplementary Online Content Zarbock A, Schmidt C, Van Aken H, et al; for the RenalRIPC Investigators. Effect of remote ischemic preconditioning on kidney injury among high-risk patients undergoing cardiac
More informationSoto K, Coelho S, et al. Hospital Fernando Fonseca
SEPTIC INDUCED ACUTE KIDNEY INJURY Soto K, Coelho S, et al. Hospital Fernando Fonseca Introduction- Epidemiology RIFLE/AKIN Classification Scheme for AKI diagnosis 4.2 23 53 % Absence of other clear and
More informationEvaluation of 32 urine biomarkers to predict the progression of acute kidney injury after cardiac surgery
http://www.kidney-international.org & 2013 International Society of Nephrology clinical investigation Evaluation of 32 urine biomarkers to predict the progression of acute kidney injury after cardiac surgery
More informationDuration of anuria predicts recovery of renal function after acute kidney injury requiring continuous renal replacement therapy
ORIGINAL ARTICLE Korean J Intern Med 2016;31:930-937 Duration of anuria predicts recovery of renal function after acute kidney injury requiring continuous renal replacement therapy Hee-Yeon Jung *, Jong-Hak
More informationPaul R. Bowlin, M.D. University of Colorado Denver. May 12 th, 2008
Paul R. Bowlin, M.D. University of Colorado Denver May 12 th, 2008 Presentation Overview Background / Definitions History Indications for initiation of therapy Outcomes Studies Conclusions Questions Background
More informationWhen and how to start RRT in critically ill patients? Intensive Care Training Program Radboud University Medical Centre Nijmegen
When and how to start RRT in critically ill patients? Intensive Care Training Program Radboud University Medical Centre Nijmegen Case history (1) 64 Hypertension 2004 AVR 2009 Paravalvular leak - dilated
More informationSupplementary Online Content
Supplementary Online Content James MT, Neesh P, Hemmelgarn BR, et al. Derivation and external validation of prediction models for advanced chronic kidney disease following acute kidney injury. JAMA. doi:10.1001/jama.2017.16326
More informationProfessor and Director. Children s Hospital of Richmond
Evaluation of AKI in term and premature infants Timothy E. Bunchman Professor and Director Pediatric Nephrology & Transplantation Children s Hospital of Richmond Virginia Commonwealth Univ. School of Medicine
More informationCaring for the AKI Survivor: What is Required?
Caring for the AKI Survivor: What is Required? Ron Wald, MDCM MPH FRCPC Division of Nephrology St. Michael s Hospital and University of Toronto February 28, 2019 A patient in your ICU 65M with DM, HTN,
More informationDuration of acute kidney injury in critically ill patients
https://doi.org/10.1186/s13613-018-0374-x RESEARCH Open Access Duration of acute kidney injury in critically ill patients Christine K. Federspiel 1,2, Theis S. Itenov 2, Kala Mehta 3, Raymond K. Hsu 4,
More informationBiological markers for kidney injury and renal function in the intensive care unit Royakkers, A.A.N.M.
UvA-DARE (Digital Academic Repository) Biological markers for kidney injury and renal function in the intensive care unit Royakkers, A.A.N.M. Link to publication Citation for published version (APA): Royakkers,
More informationAcute kidney injury definition, causes and pathophysiology. Financial Disclosure. Some History Trivia. Key Points. What is AKI
Acute kidney injury definition, causes and pathophysiology Financial Disclosure Current support: Center for Sepsis and Critical Illness Award P50 GM-111152 from the National Institute of General Medical
More informationInternational Journal of Medical and Health Sciences
International Journal of Medical and Health Sciences Journal Home Page: http://www.ijmhs.net ISSN:2277-4505 Original article Incidences and clinical outcomes of acute kidney injury in PICU: A prospective
More informationRENAL FUNCTION BIOMARKERS
HERNÁN TRIMARCHI HOSPITAL BRITÁNICO DE BUENOS AIRES ARGENTINA 2015 1 DISCLOSURES Served as a consultant and/or has received lecture honoraria from: ALEXION BRISTOL MYERS SQUIBB GENZYME NOVARTIS PFIZER
More informationPredictors of renal recovery in patients with severe acute kidney injury on renal replacement therapy
Predictors of renal recovery in patients with severe acute kidney injury on renal replacement therapy Protocol version 10 02/02/2018 1 BACKGROUND The incidence of acute kidney injury (AKI) is increasing
More informationChronic Renal Failure Followed by Acute Renal Failure
Chronic Renal Failure Followed by Acute Renal Failure Dr Emre Karakoç Çukurova Üniversity Department of Medical ICU Terminology Acute Kidney Injury Chronic Kidney Disease Acute Kidney Disease Acute kidney
More informationTiming, Dosing and Selecting of modality of RRT for AKI - the ERBP position statement
Timing, Dosing and Selecting of modality of RRT for AKI - the ERBP position statement Prof. Dr. Achim Jörres Dept. of Nephrology and Medical Intensive Care Charité University Hospital Campus Virchow Klinikum
More informationThe Association between Renin-Angiotensin System Blockade, Premorbid Blood Pressure Control, and Acute Kidney Injury in Critically Ill Patients
ICU AKI RAS A The Association between Renin-Angiotensin System Blockade, Premorbid Blood Pressure Control, and Acute Kidney Injury in Critically Ill Patients Acute Kidney Injury: AKI KDIGO ICU A 30 60%
More informationCardiorenal Biomarkers and Heart Failure. Nicholas Wettersten, MD April 7 th, 2017
Cardiorenal Biomarkers and Heart Failure Nicholas Wettersten, MD April 7 th, 2017 Disclosures Still none, but looking for some Acute Kidney Injury Biomarkers 547 in 2015 4112 as of March 2017 Case 1 60
More informationRationale for renal replacement therapy in ICU: indications, approaches and outcomes. Richard Beale
Rationale for renal replacement therapy in ICU: indications, approaches and outcomes Richard Beale RIFLE classification (ADQI group) 2004 Outcome AKIN classification Definition: Abrupt (within 48 hrs)
More informationSPRINT: Consequences for CKD patients
SPRINT: Consequences for CKD patients 29 e Workshop Nierziekten Papendal 2018 December 12, 2018 MICHAEL ROCCO, MD, MSCE VARDAMAN M. BUCKALEW JR. PROFESSOR OF MEDICINE PROFESSOR OF PUBLIC HEALTH SCIENCES
More informationREVIEW ARTICLE NEWER BIOMARKERS IN EARLY DIABETIC NEPHROPATHY
JCD REVIEW ARTICLE NEWER BIOMARKERS IN EARLY DIABETIC NEPHROPATHY SAPTARSHI MUKHOPADHYAY* *FACULTY (DEPARTMENT OF MEDICINE), B R SINGH HOSPITAL (EASTERN RAILWAY), KOLKATA. INTRODUCTION renal disease. It
More informationUrinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes
http://www.kidney-international.org & 2011 International Society of Nephrology original article see commentary on page 332 Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from
More informationBiomarkers in Acute Kidney Injury
Biomarkers in Acute Kidney Injury Mark D. Okusa, M.D. Chief, Division of Nephrology Center for Immunity, Inflammation and Regenerative Medicine University of Virginia Health System Population incidence
More informationWho? Dialysis for Acute Renal Failure: Who, What, How, and When? Kathleen D. Liu, MD, PhD, MAS June 2011
Dialysis for Acute Renal Failure: Who, What, How, and When? Kathleen D. Liu, MD, PhD, MAS June 2011 Dorre Nicholau MD PhD Clinical Professor Department of Anesthesia and Perioperative Care University of
More informationAcute Kidney Injury in Trauma. David Lee Skinner MBChB FCS(SA) Trauma Unit Inkosi Albert Luthuli Central Hospital KwaZulu Natal South Africa
Acute Kidney Injury in Trauma David Lee Skinner MBChB FCS(SA) Trauma Unit Inkosi Albert Luthuli Central Hospital KwaZulu Natal South Africa Acute Kidney Injury Acute Renal Failure RIFLE & AKIN RIFLE criteria
More informationPrédire la récupéra1on rénale. Michaël DARMON Réanima1on polyvalente CHU de Saint- E1enne
Prédire la récupéra1on rénale Michaël DARMON Réanima1on polyvalente CHU de Saint- E1enne Non- specific AKI in the ICU Lameire et al. Lancet 2005 The classical view Intense renal vasoconstric1on r= - 0.82;
More informationChemokines and trefoil factor peptides in patients suffering from chronic kidney disease
Defensio dissertationis Vienna, 03.10.2017 Chemokines and trefoil factor peptides in patients suffering from chronic kidney disease Doctoral thesis at the Medical University of Vienna for obtaining the
More informationRenal failure in sepsis and septic shock
Renal failure in sepsis and septic shock Dr. Venugopal Reddy. MD, EDIC, FCARCSI Associate Professor of Anesthesiology and Critical Care medicine Department of Anaesthesia and CCM Penn State College of
More informationThe cell cycle biomarkers: promising research, but do not oversell them
CKJ REVIEW Clinical Kidney Journal, 2016, vol. 9, no. 3, 353 358 doi: 10.1093/ckj/sfw033 Advance Access Publication Date: 24 May 2016 CKJ Review The cell cycle biomarkers: promising research, but do not
More informationThe RIFLE and AKIN classifications for acute kidney injury: a critical and comprehensive review
Clin Kidney J (2013) 6: 8 14 doi: 10.1093/ckj/sfs160 In Depth Review The RIFLE and AKIN classifications for acute kidney injury: a critical and comprehensive review José António Lopes and Sofia Jorge Department
More informationJMSCR Vol 04 Issue 12 Page December 2016
www.jmscr.igmpublication.org Impact Factor 5.244 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v4i12.19 Clinical Profile of Acute Kidney Injury:
More informationJMSCR Vol 06 Issue 12 Page December 2018
www.jmscr.igmpublication.org Impact Factor (SJIF): 6.379 Index Copernicus Value: 79.54 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v6i12.02 Original Research Article Fractional
More informationAcute renal failure Definition and detection
Acute renal failure Definition and detection Pierre Delanaye, MD, PhD Nephrology, Dialysis, Transplantation CHU Sart Tilman University of Liège BELGIUM Definition Acute Renal Failure Acute Kidney Injury
More informationWho should get a Biomarker Assessment? A focus on Biomarkers you may have at your hospital and risk scores
Who should get a Biomarker Assessment? A focus on Biomarkers you may have at your hospital and risk scores Jay L. Koyner MD Section of Nephrology Department of Medicine University of Chicago Disclosures
More informationCommonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury
http://www.kidney-international.org & 2010 International Society of Nephrology Commonly used surrogates for baseline renal function affect the classification and prognosis of acute kidney injury Edward
More informationIts 2:45 am, and Angela Johnson,
SCIENTIFIC REVIEWS Acute kidney injury John A. Kellum, MD, FCCM Diagnosis and classification of acute pathology in the kidney are major clinical problems. Azotemia and oliguria represent not only disease
More informationEarlier diagnosis of acute kidney injury in critically ill patients by novel biomarkers: Moving from supportive care to targeted renoprotection?
Anaesthesiology, Perioperative & Critical Care Medicine Page 1 of 6 Earlier diagnosis of acute kidney injury in critically ill patients by novel biomarkers: Moving from supportive care to targeted renoprotection?
More informationOriginal Article. Correspondence and offprint requests to: Matthew T. James;
Nephrol Dial Transplant (2016) 31: 2049 2056 doi: 10.1093/ndt/gfw374 Original Article Prognostic implications of adding urine output to serum creatinine measurements for staging of acute kidney injury
More informationKinetic estimated glomerular filtration rate in critically ill patients: beyond the acute kidney injury severity classification system
de Oliveira Marques et al. Critical Care (2017) 21:280 DOI 10.1186/s13054-017-1873-0 RESEARCH Kinetic estimated glomerular filtration rate in critically ill patients: beyond the acute kidney injury severity
More informationResearch Article Assessment of Cell-Cycle Arrest Biomarkers to Predict Early and Delayed Acute Kidney Injury
Disease Markers Volume 215, Article ID 158658, 9 pages http://dx.doi.org/1.1155/215/158658 Research Article Assessment of Cell-Cycle Arrest Biomarkers to Predict Early and Delayed Acute Kidney Injury Max
More informationUniversity of Groningen. Acute kidney injury after cardiac surgery Loef, Berthus Gerard
University of Groningen Acute kidney injury after cardiac surgery Loef, Berthus Gerard IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it.
More informationDefining urine output criterion for acute kidney injury in critically ill patients
Nephrol Dial Transplant (2011) 26: 509 515 doi: 10.1093/ndt/gfq332 Advance Access publication 17 June 2010 Original Articles Defining urine output criterion for acute kidney injury in critically ill patients
More informationAhmad Kaddourah, M.D., Rajit K. Basu, M.D., Sean M. Bagshaw, M.D., and Stuart L. Goldstein, M.D., for the AWARE Investigators* abstract
The new england journal of medicine established in 1812 January 5, 2017 vol. 376 no. 1 Epidemiology of Acute Kidney Injury in Critically Ill Children and Young Adults Ahmad Kaddourah, M.D., Rajit K. Basu,
More informationBlood purification in sepsis
Blood purification in sepsis Joannes-Boyau O Dept of anesthesiology and intensive care, University Hospital of Bordeaux, France 1 Types of Blood Purification hemofilters regular pore size (MW < 40,000D)
More informationNIH Public Access Author Manuscript Kidney Int. Author manuscript; available in PMC 2013 October 02.
NIH Public Access Author Manuscript Published in final edited form as: Kidney Int. 2012 March ; 81(5): 442 448. doi:10.1038/ki.2011.379. Chronic Kidney Disease after Acute Kidney Injury: A Systematic Review
More informationCKD and risk management : NICE guideline
CKD and risk management : NICE guideline 2008-2014 Shahed Ahmed Consultant Nephrologist shahed.ahmed@rlbuht.nhs.uk Key points : Changing parameters of CKD and NICE guidance CKD and age related change of
More informationDisclosures. Acute Kidney Injury. Outline. Do electronic alerts improve the care of patients with AKI? 5/9/2015
Disclosures Acute Kidney Injury Kathleen D. Liu, MD, PhD May 2015 Consultant: Achaogen, Chemocentryx, Durect, Z Pharma Clinical trials adjudication: Astute Funding: NIH Stockholder: Amgen Outline patients
More informationInternational Journal of Advanced Research in Biological Sciences ISSN: Coden: IJARQG(USA) Research Article
International Journal of Advanced Research in Biological Sciences ISSN: 2348-8069 www.ijarbs.com Coden: IJARQG(USA) Research Article Serum Neutrophil gelatinase-associated lipocalin, a novel biomarker
More informationThe role of the Nephrologist in Acute Kidney Injury. Rebecca Brown Consultant Nephrologist Royal Liverpool University Hospital
The role of the Nephrologist in Acute Kidney Injury Rebecca Brown Consultant Nephrologist Royal Liverpool University Hospital Overview Impact of AKI Need for change Who needs a Nephrologist Are we making
More informationChapter 5: Acute Kidney Injury
Chapter 5: Acute Kidney Injury Introduction In recent years, acute kidney injury (AKI) has gained increasing recognition as a major risk factor for the development of chronic kidney disease (CKD). The
More informationMeasure Abbreviation: AKI 01 (QCDR Measure ID: ASPIRE19)
Measure Abbreviation: AKI 01 (QCDR Measure ID: ASPIRE19) Data Collection Method: This measure is calculated based on data extracted from the electronic medical record combined with administrative data
More informationActual versus ideal body weight for acute kidney injury diagnosis and classification in critically Ill patients
Thongprayoon et al. BMC Nephrology 2014, 15:176 RESEARCH ARTICLE Open Access Actual versus ideal body weight for acute kidney injury diagnosis and classification in critically Ill patients Charat Thongprayoon
More informationNEPHROCHECK. Know earlier. Intervene sooner. Avoid the danger and damage of Acute Kidney Injury.
Know earlier. Intervene sooner. Avoid the danger and damage of Acute Kidney Injury. 42% of critically ill patients with Sepsis develop AKI 1 2 SEPSIS AND ACUTE KIDNEY INJURY (AKI) ARE OFTEN CO-MORBIDITIES.
More informationHospital-acquired Acute Kidney Injury: An Analysis of Nadir-to-Peak Serum Creatinine Increments Stratified by Baseline Estimated GFR
Article Hospital-acquired Acute Kidney Injury: An Analysis of Nadir-to-Peak Serum Creatinine Increments Stratified by Baseline Estimated GFR Jose Calvo Broce,* Lori Lyn Price, Orfeas Liangos, Katrin Uhlig,*
More informationThe role of microcirculatory and mitochondrial dysfunction in sepsisinduced acute kidney injury (AKI): a. model of sepsis-induced organ dysfunction
The role of microcirculatory and mitochondrial dysfunction in sepsisinduced acute kidney injury (AKI): a model of sepsis-induced organ dysfunction Hernando Gomez, MD Mentors: Michael R. Pinsky, MD John
More informationUse of Acute Kidney Injury Biomarkers in Clinical Trials
Use of Acute Kidney Injury Biomarkers in Clinical Trials Design Considerations Amit X. Garg MD, MA (Education), FRCPC, PhD Nephrologist, London Health Sciences Centre Professor, Medicine and Epidemiology
More informationUse of Acute Kidney Injury Biomarkers in Clinical Trials
Use of Acute Kidney Injury Biomarkers in Clinical Trials Design Considerations Amit X. Garg MD, MA (Education), FRCPC, PhD Nephrologist, London Health Sciences Centre Professor, Medicine and Epidemiology
More informationThe Japanese Clinical Practice Guideline for acute kidney injury 2016
Doi et al. Journal of Intensive Care (2018) 6:48 https://doi.org/10.1186/s40560-018-0308-6 GUIDELINE The Japanese Clinical Practice Guideline for acute kidney injury 2016 Open Access Kent Doi 1, Osamu
More informationThe data collection in this study was approved by the Institutional Research Ethics
Additional materials. The data collection in this study was approved by the Institutional Research Ethics Review Boards (201409024RINB in National Taiwan University Hospital, 01-X16-059 in Buddhist Tzu
More informationEvidence-based practice in nephrology : Meta-analysis
Evidence-based practice in nephrology : Meta-analysis Paweena Susantitaphong, MD,Ph.D 1-3 1 Associate Professor, Division of Nephrology, Department of Medicine, King Chulalongkorn Memorial Hospital, Chulalongkorn
More informationThe prognostic importance of duration of AKI: a systematic review and meta-analysis
Mehta et al. BMC Nephrology (2018) 19:91 https://doi.org/10.1186/s12882-018-0876-7 RESEARCH ARTICLE Open Access The prognostic importance of duration of AKI: a systematic review and meta-analysis Swati
More information